![David Liberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Liberg
Chief Tech/Sci/R&D Officer at
CANTARGIA AB
Net worth: 15 319 $ as of 2026-06-29
Profile
David Liberg is currently the Chief Scientific Officer at Cantargia AB. He previously worked as a Project Manager-Drug Development at Active Biotech AB.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CANTARGIA AB 0.03% | 2024-12-30 | 69,087 ( 0.03% ) | 15 319 $ | 2026-06-29 |
David Liberg active positions
| Companies | Position | Start |
|---|---|---|
| CANTARGIA AB | Chief Tech/Sci/R&D Officer | 2014-12-31 |
Former positions of David Liberg
| Companies | Position | End |
|---|---|---|
| ACTIVE BIOTECH AB | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
- Stock Market
- Insiders
- David Liberg
